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Abstract: The status of trail running races has exponentially grown in recent years. The present
study aimed to: (a) evaluate the acute response of ultratrail racing in terms of neuromuscular
function, muscle damage and hydration status; (b) analyze if responses could differ according to
training levels. Twenty runners participated in the present study. The participants were divided into
amateur training level (n = 10; 43.30 ± 4.52 years) or high level competitors (n = 10; 41.40 ± 6.18).
Neuromuscular response (squat jump, countermovement jump and Abalakov jump), muscle damage
(alanine aminotransferase, bilirubin, creatine kinase and leukocytes) and hydration status (sodium
and creatinine) were evaluated before and after the Guara Somontano Ultratrail Race (108 km distance,
with an accumulated slope of 5800 m). The height and power achieved by vertical jumps were lower
after the race (p < 0.001). The post-race muscle damage and creatinine parameters increased in both
groups (p < 0.001). The high-level group obtained lower percentages of change in squat jump and
countermovement jump than the amateur-level group (p < 0.05). However, the increase in creatinine
was greater for the high-level group (p < 0.05). Ultratrail racing reduces neuromuscular function
and increases muscle damage. High-level runners showed less neuromuscular fatigue compared to
amateur ones.
Keywords: trail running; jump; neuromuscular; hydration
1. Introduction
Ultratrail is a form of very long-distance mountain racing included in trail running.
Given its extreme characteristics, this kind of racing can be considered very taxing, or even
dangerous, for our organism [1]. Ultratrail racing is performed on routes with adverse
orography. Its distance exceeds that of marathons [2,3], and ranges between 80 km and
300 km [4]. The fact that ultratrail runners face unstable environmental and weather
conditions for long periods of time, and constant changes in the topography of land and
altitude [4], with considerable positive and negative slopes [5], is also emphasized.
Despite trail running races being extremely hard, the organization of the sport has
exponentially grown worldwide in recent times [6–8], and Spain is no exception [9]. The
marked demand expected today of such races has drawn more participants, to the extent
that the number of runners in races must be limited, which has led to some runners
becoming professionals with enhanced ultratrail race performance [10].
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Ultratrail races are multifactorial events that include physiological, neuromuscular,
biomechanical and psychological variables [2]. Depending on exertion while running these
races, research works indicate that according to ventilator thresholds (VT), in physiological
terms these races place mean training intensities at 85.7% for zone I (<VT1), 13.9% for zone
II (VT1–VT2) and 0.4% for zone III (>VT2) [11]. Cardiac responses during races lasting
between 14 and 7 h present intensities of 64% [12] and 82% [13] of maximum heart rate
(HRmax), respectively. Different research works have analyzed lactate kinetics during such
races, and have obtained results that are below the onset of blood lactate accumulation
(OBLA) [14,15]. Finally, as regards the psychophysiological component, values between 13
and 14 points have been obtained on the rate perceived exertion (RPE) scale [16].
In ultratrail endurance races, optimum performance might depend on high maximal
oxygen consumption (VO2max) levels, high VO2max fraction utilization percentages and
low oxygen transport cost [2]. Along these lines, it has been demonstrated that maximum
aerobic power can be a limiting factor to running on positive slopes [17], which are usual
for ultratrail routes. When considering the types of routes that ultratrail races are organized
along, it would appear that adapting to exertions, in which eccentric-type activations
predominate, could be important for facing the ascents and constant loads that come
into play when running on irregular sloping surfaces. The eccentric capacity to maintain
maximum racing speed would be a determining factor in zones with negative slopes [18].
The increasing numbers of both participants and ultratrail races have favored different
research studies being performed in an attempt to analyze the impact that this racing
has on health. Indeed, ultratrail races have been associated with a negative energy bal-
ance [13], muscle harm and inflammation [19,20], neuromuscular fatigue [21,22], cardiac
dysfunctions, myocardial damage [13] and dehydration [1].
The relationship between hydration status and performance has been described [23,24].
Hydration status is directly related to physical performance [25]. Previous studies have
reported the consequences of dehydration at the physical level, which can negatively affect
sports performance [26,27]. A small decrement in hydration status impaired physiologic
function and performance during a trail running race [28]. In addition, dehydration status
could negatively affect the neuromuscular response [29].
Bearing in mind the marked physical stress that the organism is submitted to while
running an ultratrail race, it can be stated that running such races in an unplanned and
uncontrolled manner can have very negative consequences for the health of the people
practicing this sport [1]. Indeed, knowing the limits of the organism’s physiological
responses while practicing long intense exercise is necessary to avoid resorting to urgent
medical assistance [30]. However, the impact of an ultratrail race could differ from one
individual to another because they have distinct training levels. This means that more
studies need to be conducted to elucidate this statement [31,32]. The impacts of such
races could be very different depending on the participants’ training levels, owing to their
distinct physiological profiles [33]. Hence, the objectives of the present study were to:
(a) evaluate the acute responses to an ultratrail race in terms of neuromuscular function,
muscle damage and hydration status; (b) analyze if responses could differ according to
training levels.
2. Materials and Methods
2.1. Participants
Twenty runners participated in this quasiexperimental study, and were divided into
an amateur-level group (n = 10) and a high-level group (n = 10) according to their training
levels [34]. The high-level group was made up of runners who trained for a minimum
of 8 h/week and achieved positive accumulated slopes of more than 50,000 m in the 12
months before the test. The amateur group was formed by those runners who did not
meet any of the set requirements. The study was conducted on a population of 176 male
participants who completed the race. The minimum sample size was 20 participants
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(confidence level = 95%; margin of error = 21%). The characteristics of the participants in
each group are found in Table 1.
Table 1. Characteristics of our participants.
Parameters Amateur Level (n = 10) High Level (n = 10) p
Age (years) 43.30 ± 4.52 41.40 ± 6.18 0.443
Height (m) 1.77 ± 0.06 1.76 ± 0.06 0.780
Experience (year) 5.80 ± 2.52 4.60 ± 1.26 0.196
Weekly training (h) 6.50 ± 0.70 11.05 ± 2.94 <0.001
Annual slopes (m) 33,716.7 ± 4427.7 56,426.6 ± 8184.6 0.001
All the participants were informed about the study purpose and signed a consent form
before enrolling. The protocol was reviewed and approved by the Ethical Committee of
Clinical Research of Aragon (Spain) following the guidelines of the Helsinki Declaration of
Ethics, updated at the World Medical Assembly in Fortaleza (2013) for research involving
human subjects. A code was assigned to each participant to collect and treat samples in
order to maintain their anonymity.
In order to participate in this study, the participants had to meet the following inclusion
criteria: (a) male; (b) finished the race route; (c) had no injuries after a race in at least the 2
months prior to the test; (d) not on a special diet or any pharmacological treatment; (e) no
cardiovascular or metabolic diseases.
2.2. Procedures
This study was carried out while organizing the Guara Somontano UltraTrail Race
(GSUR) (Figure 1), which took place in the town of Alquézar (Huesca, Spain). The total
race distance was 108 km, with 5800 meters of positive accumulated slope. The maximum
permitted time to finish it in was 24 h. During this race the mean temperature was
14 ± 4.4 °C and relative humidity was 57 ± 16.1% (Figure 1).




Figure 1. Race profile (taken from the organization’s website). 
2.3. Anthropometric Measurements 
The participants’ morphological characteristics were evaluated in the morning and 
always under the same conditions. Body height was measured to the nearest 0.1 cm using 
a wall-mounted stadiometer (Seca 220, Seca, Hamburg, Germany). Body weight was 
measured to the nearest 0.01 kg on calibrated electronic digital scales (Seca 769, Seca, 
Hamburg, Germany), barefooted. A Holtain© 610ND (Holtain, Crymych, Wales, UK) skin 
fold compass, accurate to ±0.2 mm and a tape (Seca 212, Seca, Hamburg, Germany) with 
an accuracy of ±1 mm were employed to take anthropometric assessments. The obtained 
anthropometric measurements were height, weight, six skin folds (abdominal, suprailiac, 
subscapular, tricipital, thigh and leg) and perimeters (arm and leg in a relaxed 90° posi-
tion). The equations of Yushaz were used to calculate the percentage of fat [35] and the 
equation according to Lee to determine the percentage of muscle [36]. All the measure-
ments were taken by the same operator, who was skilled in kinanthropometric techniques, 
and in accordance with the International Society for the Advancement of Kinanthropom-
etry recommendations [37]. Body weight was recorded 2 h before and immediately after 
the race finished. 
2.4. Physical Performance Evaluation 
In order to determine the corresponding physical performance values, a progressive 
and maximum laboratory test was done on a treadmill (Pulsar, h/p/cosmos®, Nussdorf, 
Germany). The test was run on a 1% slope and began at a speed of 8 km/h, which increased 
1 km/h every minute. Before the test began, the participants warmed up for 5 minutes on 
the treadmill operating at a speed of 6 km.h-1. Respired gases were collected with an Ox-
ycon Pro analyzer (Erich Jaeger GmbH, Hoechberg, Germany). A pulsometer (Vantage M, 
Polar, Finland) was used to evaluate the maximal heart rate. 
2.5. Neuromuscular Function 
Neuromuscular function was evaluated by different jumping tests: squat jump (SJ), 
countermovement jump (CMJ) and Abalakov jump (ABK) [38,39]. The former tests were 
chosen to measure the neuromuscular function of leg extensor muscles, because they can 
perform jumps with a high degree of reliability [40,41]. A jump mat system (Chronojump 
Boscosystems, Barcelona, Spain) was employed to measure the height and time during 
jumps. Three attempts were made for all jump types; there was a 30-second rest between 
jumps. The best jump was selected to be later analyzed. Evaluations were done 2 h before 
Figure 1. ace profile (taken fro the organization’s ebsite).
The week before competition, the participants underwent body composition and
physical performance evaluations. In parallel to these evaluations, the runners completed
an open ad hoc survey with supplementary information about their experience, and the
characteristics of their training over the past year (h/week and accumulated slope). To
determine hydration during races, the volumes of liquids drunk by racers were calculated
at both supply points and throughout the race according to individual drinking frequency.
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Volunteers recorded the amounts of water ingested at each supply point using two 250 cc
bottles as a reference. At each refreshment point, two 250 cc bottles were given to each
participant.
2.3. Anthropometric Measurements
The participants’ morphological characteristics were evaluated in the morning and
always under the same conditions. Body height was measured to the nearest 0.1 cm
using a wall-mounted stadiometer (Seca 220, Seca, Hamburg, Germany). Body weight
was measured to the nearest 0.01 kg on calibrated electronic digital scales (Seca 769, Seca,
Hamburg, Germany), barefooted. A Holtain© 610ND (Holtain, Crymych, Wales, UK) skin
fold compass, accurate to ±0.2 mm and a tape (Seca 212, Seca, Hamburg, Germany) with
an accuracy of ±1 mm were employed to take anthropometric assessments. The obtained
anthropometric measurements were height, weight, six skin folds (abdominal, suprailiac,
subscapular, tricipital, thigh and leg) and perimeters (arm and leg in a relaxed 90◦ position).
The equations of Yushaz were used to calculate the percentage of fat [35] and the equation
according to Lee to determine the percentage of muscle [36]. All the measurements were
taken by the same operator, who was skilled in kinanthropometric techniques, and in
accordance with the International Society for the Advancement of Kinanthropometry
recommendations [37]. Body weight was recorded 2 h before and immediately after the
race finished.
2.4. Physical Performance Evaluation
In order to determine the corresponding physical performance values, a progressive
and maximum laboratory test was done on a treadmill (Pulsar, h/p/cosmos®, Nussdorf,
Germany). The test was run on a 1% slope and began at a speed of 8 km/h, which increased
1 km/h every minute. Before the test began, the participants warmed up for 5 min on the
treadmill operating at a speed of 6 km.h−1. Respired gases were collected with an Oxycon
Pro analyzer (Erich Jaeger GmbH, Hoechberg, Germany). A pulsometer (Vantage M, Polar,
Finland) was used to evaluate the maximal heart rate.
2.5. Neuromuscular Function
Neuromuscular function was evaluated by different jumping tests: squat jump (SJ),
countermovement jump (CMJ) and Abalakov jump (ABK) [38,39]. The former tests were
chosen to measure the neuromuscular function of leg extensor muscles, because they can
perform jumps with a high degree of reliability [40,41]. A jump mat system (Chronojump
Boscosystems, Barcelona, Spain) was employed to measure the height and time during
jumps. Three attempts were made for all jump types; there was a 30-s rest between jumps.
The best jump was selected to be later analyzed. Evaluations were done 2 h before the
race began and then immediately after the race finished (approximately 1 to 5 min after
the race). The protocols of each jump test were applied by following the original protocol
proposed by Bosco et al. [39].
In order to perform SJ, the participants started in a squatting position with knees
bent at 90◦ and arms on hips to avoid influencing the jump. A goniometer was used to
verify the knee angle. The participants had to remain in this squatting position for 3 s
before performing SJ. For CMJ, the subjects started from an upright standing position with
hands on hips to avoid any arm movement. Then as a single sequence, they made a swift
downward movement, followed immediately by a rapid vertical movement to jump as
high as possible. Finally, during the ABK test, the participants had to begin by squatting
and flexing their knees 90◦, followed by swinging their arms to help them to jump as high
as possible.
2.6. Blood Samples
Twenty milliliters of venous blood (antecubital vein) was withdrawn from each partic-
ipant in both the pre- and post-race evaluations (90 min before and 10 min after finishing
Int. J. Environ. Res. Public Health 2021, 18, 5119 5 of 14
the race). Blood samples were collected in two 5-mL Vacutainer tubes (Vacutainer, beliver
industrial state, plymouth PL6 7BP, United Kingdom) without anticoagulant for serum
isolation and in two 5-mL tubes containing ethylenediaminetetraacetic acid (EDTA) as an
anticoagulant. Once collected, blood samples were coagulated for 25–30 min at room tem-
perature and then centrifuged at 2500 rpm for 10 min to remove the clots. Serum samples
were aliquoted into Eppendorf tubes (Eppendorf AG, Hamburg, Germany), previously
washed with diluted nitric acid, and conserved at −80 °C until the biochemical analysis.
2.7. Determining Muscle Damage Markers and Hydration Status
A 2-mL blood sample was used to determine leukocytes (leu) with an analyzer model
Coulter model AcT diff. The rest, a 3-mL blood sample, was employed to determine
creatinine (Cr), alanine aminotransferase (ALT), creatine kinase (CK), sodium (Na) and
bilirubin (BIL) by spectrophotometric techniques. Complete biochemistry was processed in
the laboratory of the San Jorge University Hospital by a Chemistry Analyzer model Advia
1650 (Bayer, Germany).
2.8. Statistical Analysis
Data were processed with IBM SPSS 25.0 Statistics for Macintosh (IBM Corp., Armonk,
NY, USA). A descriptive analysis was performed to show the means and standard devia-
tions. The variables’ normality distribution was analyzed by the Shapiro–Wilk test and the
homogeneity of variances by the Levene test. The Student’s t-test was applied to determine
differences in the participants’ characteristics and the percentages of change (pre-race vs.
post-race). A two-way ANOVA (group effect + race effect) was used to show differences
between the studied variables. Effect size was calculated for the two-way ANOVA using
partial eta-squared (η2) as a low effect (0.01–0.06), moderate effect (0.06–0.14) and high
effect (>0.14) [42]. The p < 0.05 differences were considered statistically significant.
3. Results
Table 2 shows the characteristics of the participants in both groups. Significant dif-
ferences existed in weekly training hours, annual slope achieved while training, times
recorded during the GSUR test, maximum speed and percentage of fat (p < 0.05).
Table 2. Body composition, physical tests and result during GSUR.
Parameters Amateur Level(n = 10) High Level (n = 10) p
Time during the race (h) 19.87 ± 1.84 15.31 ± 0.81 <0.001
VO2max (L/min) 4.11 ± 0.37 4.46 ± 0.45 0.079
HRmax (bpm) 179.50 ± 7.20 177.29 ± 6.76 0.605
Maximum speed (km/h) 15.00 ± 0.81 16.40 ± 0.96 0.003
Fat mass (%) 10.72 ± 2.28 8.83 ± 1.45 0.040
Muscle mass (%) 43.40 ± 3.65 45.07 ± 2.93 0.276
Water intake (L) 9.64 ± 3.08 11.17 ± 3.79 0.337
VO2max: maximal oxygen consumption; HRmax: maximum heart rate.
Tables 3 and 4 indicate the changes in neuromuscular function, muscle damage
and dehydration before and after the race, as well as intergroup differences. For these
differences, we observed significant differences for ALT and bilirubin (p < 0.05). For the
effect that racing had, we found significant differences in SJ, CMJ, ABK, CK, ALT, BIL, leu
and Cr (p < 0.001). Finally, we observed significant differences in bilirubin when the group
x race interaction was analyzed (p < 0.05).
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Table 3. Neuromuscular function before and after the race according to training level.











Pre 25.50 ± 4.38 27.12 ± 5.29
0.102 0.072 <0.001 0.470 0.597 0.008Post 16.74 ± 3.91 19.87 ± 4.31
CMJ (cm)
Pre 29.86 ± 5.08 31.14 ± 6.33
0.182 0.049 <0.001 0.430 0.554 0.010Post 20.11 ± 5.01 23.39 ± 4.64
ABK (cm)
Pre 34.08 ± 6.44 36.66 ± 8.93
0.189 0.047 <0.001 0.360 0.922 0.000Post 24.52 ± 4.88 27.51 ± 5.25
SJ (W)
Pre 810.80 ± 78.87 821.20 ± 91.68
0.638 0.006 <0.001 0.327 0.906 0.000Post 684.80 ± 71.57 702.20 ± 120.62
CMJ (W)
Pre 876.90 ± 84.09 866.00 ± 107.53
0.659 0.005 <0.001 0.290 0.420 0.018Post 740.10 ± 71.11 777.20 ± 103.15
ABK (W)
Pre 935.30 ± 79.98 950.20 ± 106.14
0.663 0.005 <0.001 0.333 0.949 0.000Post 811.80 ± 95.25 822.90 ± 90.97
CMJ: countermovement jump; SJ: squat jump; ABK: Abalakov jump; η2: eta-squared.
Table 4. Weight, muscle harm parameters and hydration status before and after the race according to training level.










Weight (kg) Pre 76.01 ± 10.84 75.23 ± 6.87 0.640 0.006 0.474 0.014 0.846 0.001Post 74.52 ± 10.21 73.58 ± 8.56
CK (U/L)
Pre 164.30 ± 69.39 193.60 ± 42.11
0.074 0.086 <0.001 0.817 0.091 0.077Post 3251. 60 ± 1011.89 4261.50 ± 1469.60
ALT (U/L)
Pre 18.60 ± 2.50 23.50 ± 3.92
0.017 0.147 <0.001 0.537 0.904 0.000Post 31.70 ± 9.67 37.10 ± 7.46
BIL
(mg/dL)
Pre 0.597 ± 0.148 0.600 ± 0.156
0.028 0.128 <0.001 0.698 0.024 0.133Post 1.219 ± 0.205 0.967 ± 0.169
Leu
(×103/µL)
Pre 5.93 ± 1.00 5.99 ± 0.93
0.589 0.008 <0.001 0.843 0.650 0.006Post 15.04 ± 2.29 15.72 ± 3.35
Cr (mg/dL) Pre 0.900 ± 0.137 0.855 ± 0.101 0.380 0.021 <0.001 0.634 0.081 0.082Post 1.202 ± 0.239 1.335 ± 0.107
Na
(mmol/L)
Pre 140.10 ± 2.33 140.70 ± 1.76
0.194 0.046 0.432 0.017 0.599 0.008Post 140.30 ± 2.11 141.70 ± 3.12
CK: creatinine kinase; ALT: alanine aminotransferase; BIL: bilirubin; Leu: leukocytes; Cr: creatinine; Na: sodium; η2: eta-squared.
Figures 2 and 3 depict the percentages of change (pre vs. post) of the previously
studied parameters. Figure 2 illustrates the significant differences in the height of both SJ
and CMJ, and loss in the high-level group was lower (p < 0.05). Figure 3 shows differences
in creatinine (p < 0.05), for which a more marked increase was observed in the high-level
group.
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Figure 3. (A) Percentage of change in CK; (B) percentage of change in ALT; (C) percentage of change
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change in leukocytes; bl ck circle: values of amateur levels participants; black square: v lues of high
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4. Discussion
The present study’s objectives were to: (a) evaluate the acute responses of running an
ultratrail race in terms of neuromuscular function, muscle damage and hydration status; (b)
analyze if responses could differ according to training level. The GSUR reduced the power
and height of th SJ, CMJ and ABK ju p for all the participants. The uscle damage and
dehydr tion marker increa ed in both groups. However, the percentages of loss in the
SJ and CMJ heights were lower in the high-level group than in the amateur-level group
(p < 0.05). The percentage of increase in creatinine levels was higher in the high-level
group (p < 0.05). Research concerning the study of trail running has increased in recent
years [43–46]
In general, the responses observed during the GSUR were similar to those reported in
other races [12,13,47,48]. Likewise, the study participants presented similar characteristics
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to runners, as reported by former studies [22,49]. According to similar studies, ultratrail rac-
ing could have a distinct impact, particularly for neuromuscular and creatinine parameters,
depending on training level [31,32].
For the neuromuscular function parameters, significant reductions in the height and
power of all jumps were noted after the race (Table 3). These results fall in line with those
previously reported by other authors. For instance, Martínez-Navarro et al. [50] observed
lower SJ heights after races covering 65 km and 107 km. Balducci et al. [51] reported a 20%
loss in CMJ after a 75 km race, as Gatterer et al. did [52]. However, Rousanoglou et al. [53]
observed no significant differences in CMJ height after a mountain marathon race until 5
after min after finishing the race. Apart from ultratrail races being long-distance runs, they
involve marked slopes, which implies engaging a high eccentric force component [47] that
can cause high levels of muscle damage and fatigue which, in turn, have been associated
with excitation–relaxation coupling failure [54,55]. Excitation–contraction coupling failure
results in a lower free calcium level in the cytosol, and thus, in less muscle power [55,56].
Hence, ultratrail endurance mountain racing events strongly impact peripheral fatigue
by diminishing muscle function and performance [22,56]. The lower jump heights after
racing were expected due to functional alterations and the reduced capacity to produce
maximum power induced by racing characteristics [13,53]. On this matter, Millet et al. [22],
Giandolini et al. [54] and Saugy et al. [21] respectively observed how voluntary maximum
knee extensor contraction diminished (35%, 35% and 13%), as did foot flexor contraction
(39%, 28% and 10%), after mountain races. In these circumstances, it is not surprising that
jump tests are often employed to evaluate neuromuscular fatigue in muscle groups [57–59],
especially fatigue induced by ultradistance tests. In fact, after repeatedly applying jump
tests after a 90-kilometer race, Chambers et al. [60] reported significant drops in SJ and
CMJ heights, which remained for 18 consecutive days after the competition.
Our study also observed how fatigue affected the amateur-level group runners to a
greater extent because the reductions in the SJ (Figure 2A) and CMJ (Figure 2C) heights
were significantly more marked in this group. These results fall in line with what El-Ashker
et al. indicated [61], who found that the subjects with a higher level of training presented
better neuromuscular function with fatigue. Nonetheless, these intergroup differences
were not noted for either the ABK jump (Figure 2E) or developed power (W) in all jumps
(Figure 2B,D,F). These results coincide partly with those from the meta-analysis carried out
by Claudino et al. [62] because the achieved CMJ height seemed to better define the degree
of the neuromuscular fatigue of knee extensors than other jumps and kinetic parameters,
which showed a higher coefficient of variation, such as developed power.
For muscle and liver damage and inflammation, the present study observed higher
CK, ALT and bilirubin concentrations after racing. The obtained results fall in line with
those reported for mountain races covering different distances: 43 km [63], 54 km [13],
217 km [48], 280 km [64] and 330 km [65]. The CK and liver enzyme levels, among others,
were the most widespread markers to indicate skeletal muscle damage [66]. According
to data on jump tests, lower jump heights could be related to high CK and ALT levels in
blood [67]. This relation suggests that continuous eccentric actions performed on negative
slopes might damage muscle fibers, which leads to the release of muscle proteins in
the bloodstream, such as CK [13,68]. The fact that ALT rose could be related to both
muscle damage caused by eccentric contractions and liver cell lesions [69]. However, it is
known that ALT concentrations are higher in the liver and kidneys, and lower in skeletal
muscle [70]. It is also known that the degree of liver lesion is proportional to workload [71].
Likewise, a rise in bilirubin levels after a race has been found by others studies [72–74].
Increased bilirubin can be caused by hemolysis produced mainly by mechanical factors
and the effect of free radicals [75]. The percentage increase in bilirubin in the amateur level
group could have been due to the lower amount of antioxidants in this group compared to
the high-level group [75]. As an adaptation, regular physical training increases the levels
of antioxidants in the body, increasing the efficiency of the antioxidant system [76,77]. The
radicals produced during exercise could increase hemolysis and bilirubin levels.
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The rising levels of leukocytes observed in the present study fall in line with previous
studies [64,78,79]. Leukocytosis caused by running could be due to increased inflamma-
tion caused by muscle damage [80,81]. Acute physical exercise can lead to more cardiac
output, vascular vasodilatation and blood flow, which exert stronger mechanical forces
on the endothelium which, in turn, leads to leukocytes separating from the endothelium
and entering circulation [82]. Moreover, catecholamines and cortisol are secreted during
exercise, which could also contribute to increase leukocytes [81,83].
No differences were observed in the plasma Na concentration for hydration status.
Creatinine levels rose after racing (p < 0.001) and the percentage of change was higher
for the high-level group (p < 0.05). These differences are probably related to strong kid-
ney and muscle impacts. After ultratrail races, runners generally suffer dehydration and
body weight loss [1,84]. Drinking plenty of liquids during races is recommended to avoid
dehydration [1]. Different hydration strategies are used during ultratrail races to avoid
dehydration [85]. The problems of dehydration regarding metabolic and neuromuscular
performance were previously outlined [25,28]. Acute kidney lesions are often reported after
endurance races, with a prevalence of up to 80% during ultratrail running, but most do
not pose serious health problems, and kidney function normally recovers completely after
a few days [86,87]. The present study found no significant differences between drinking
liquids while racing, unlike some other studies [88]. This could be related to no differences
being found in Na concentrations. Plasma Na concentration is the most frequently used
parameter to evaluate dehydration status [89]. Former studies reported increased Na after
trail races [90,91]. The fact that our study found high creatinine concentrations in runners
coincides with previous studies [87,92]. These changes would probably have a multifacto-
rial basis, to which both dehydration and a lower exercise-related glomerular filtration rate
would contribute [93]. The fact that serum creatinine concentration positively correlates
with lean muscle mass and varies with training type has been demonstrated [88,94].
The study has its limitations: (a) its sample size was small; (b) food intake while racing
was not controlled, which could have affected the muscle and neuromuscular damage
markers, as other studies have reported [56,95]; (c) only the male gender was studied; (d) it
did not evaluate the same markers while the race was underway or in post-race hours to
evaluate evolution. As each ultratrail race is unique, these results cannot be completely
extrapolated to other races.
5. Conclusions
Ultratrail racing lowers neuromuscular function and increases muscle damage/inflammation.
High-level runners suffer less neuromuscular fatigue than amateur-level runners. However, the
creatinine levels in the high-level group increased more in metabolic terms.
It is worth knowing the impacts of trail racing in order to schedule and adapt training
sessions according to race demands. According to the obtained results, training programs
and racing strategies must include muscle damage prevention to reduce ultratrail runners’
muscle fatigue.
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